ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,768,000 | -37.8% | 360,100 | -33.2% | 0.01% | -37.5% |
| Q2 2021 | $2,844,000 | +23.9% | 538,700 | +12.7% | 0.01% | +33.3% |
| Q1 2021 | $2,295,000 | +216.6% | 478,100 | +185.4% | 0.01% | +200.0% |
| Q4 2020 | $725,000 | +94.9% | 167,500 | +85.5% | 0.00% | +100.0% |
| Q3 2020 | $372,000 | +659.2% | 90,300 | +370.3% | 0.00% | – |
| Q2 2020 | $49,000 | -89.2% | 19,200 | +1.6% | 0.00% | -100.0% |
| Q1 2018 | $452,000 | -24.2% | 18,900 | +7.4% | 0.00% | -50.0% |
| Q4 2017 | $596,000 | +196.5% | 17,600 | +147.9% | 0.00% | +100.0% |
| Q4 2015 | $201,000 | -40.5% | 7,100 | -45.0% | 0.00% | -66.7% |
| Q2 2015 | $338,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
| GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
| Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
| Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
| WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
| EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
| Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
| TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
| PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |